Latest
- March 3, 2026
Why AI’s Biggest Blind Spot In Pharma Isn’t Technical
- January 29, 2026
Pharma’s Biggest Missed AI Opportunity Is Living Evidence
- January 12, 2026
Oncoscope-AI Launches REAL-SLR library to Transform Oncology Evidence supporting Pharma R&D and Market Access Decisions
- November 14, 2025
Why Chatbots Aren’t Enough In Oncology
- October 22, 2025
Smarter Oncology, Faster Access: How Anna Forsythe and Oncoscope-AI Are Reengineering Cancer Care
- October 13, 2025
The Danger of Imperfect AI: Incomplete Results Can Steer Cancer Patients in the Wrong Direction
- September 24, 2025
From Evidence To AI: Why The Future Of Oncology Decision Support Must Be Built On Living Evidence
- September 9, 2025
From Cochrane To Chatbots: Why Evidence Matters Now More Than Ever In The AI Era
- August 28, 2025
Oncoscope-AI Launches Edge for Leaders Shaping the Next Standard of Cancer Care
- August 24, 2025
In the AI Era, Are Doctors Still at the Cutting Edge of Medicine? Oncoscope-AI Founder Anna Forsythe Asks
- June 23, 2025
Anna Forsythe’s Second Movement: How a Pianist Became a Pioneer in Cancer Intelligence
- June 12, 2025
Anna Forsythe Built Oncoscope to Give Doctors What They Actually Need: Usable Intelligence
- June 6, 2025